Progressively decreasing LMTK2 levels seen in an Alzheimer’s disease mouse model [54] could potentially lead to aberrant overactivation of GSK3β in aged mice. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.